Last Updated: February 7, 2024
The Brady Lab is interested in identifying and characterizing novel transcription factors that contribute to the process of lineage plasticity.
Last Updated: February 7, 2024
We are currently investigating how chromatin states are modulated during the progression from castration-resistant prostate cancer (CRPC) to neuroendocrine prostate cancer (NEPC).